You are viewing: Oncology Enteral Feeding Devices Market analysis
Part of: Enteral Feeding Devices Market (Global)

The Oncology Enteral Feeding Devices Market was valued at $110.4 Million in 2025 and projected to reach to $162.5 Million by 2030, representing a compound annual growth rate of 5.7%. The Enteral Feeding Devices Market is experiencing steady growth driven by increasing prevalence of chronic diseases, rising geriatric populations, and growing awareness of nutritional support therapies.

Oncology Enteral Feeding Devices Market Trends and Insights

  • Gastrostomy-Jejunostomy Tubes serve patients requiring long-term nutritional support, combining direct gastric and jejunal access for enhanced feeding flexibility and clinical outcomes.
  • The growth trajectory of Gastrostomy-Jejunostomy Tubes reflects increasing prevalence of chronic conditions, aging populations, and rising adoption of minimally invasive feeding solutions across healthcare systems globally. Gastrostomy-Jejunostomy Tubes are experiencing sustained demand driven by improved clinical protocols, enhanced product designs, and expanding reimbursement coverage.
  • The segment's 5.7% compound annual growth rate through 2030 underscores the rising preference for dual-access feeding devices that reduce complications and improve patient tolerance.
  • Gastrostomy-Jejunostomy Tubes continue to gain market share as healthcare providers recognize their therapeutic advantages in managing dysphagia, post-surgical nutrition, and complex gastrointestinal disorders..

Key Market Statistics

  • CAGR (2025-2030) 5.7% CAGR
  • Market Size, 2025 ~USD 110.4 Million
  • Forecast, 2030 ~USD 162.5 Million
  • Geography Oncology

Oncology Enteral Feeding Devices Market Overview

Market Growth Trajectory :

The Enteral Feeding Devices Market is projected to grow from $3.27 billion in 2025 to $4.76 billion by 2039, representing a steady CAGR of 5.5% over the forecast period.

Comprehensive Segment Coverage :

The market analysis covers six key segments including Product, Type, Age Group, Insertion Method, Application, and End User, providing detailed insights across all major market dimensions.

Global Market Reach :

The report encompasses global market analysis with regional breakdowns for North America, Europe, and Asia Pacific, along with disease-specific insights for Oncology and Gastrointestinal Disorders.

Long-term Forecast Horizon :

With a 14-year forecast period extending to 2039, the report provides strategic insights for long-term business planning and market positioning in the enteral feeding devices sector.

Oncology Enteral Feeding Devices Market Dynamics

  • The market's expansion is supported by technological advancements in feeding device design, improved patient comfort features, and enhanced clinical outcomes.
  • Healthcare providers are increasingly adopting enteral feeding solutions as a cost-effective alternative to parenteral nutrition. Looking ahead to 2039, the market is expected to benefit from expanding healthcare infrastructure in emerging economies, growing investment in home healthcare services, and rising demand for minimally invasive feeding solutions.
  • The integration of digital monitoring technologies and improved device materials will further drive market adoption.
  • Additionally, increasing prevalence of gastrointestinal disorders and cancer-related nutritional challenges will continue to fuel demand across diverse patient populations and healthcare settings..

Related Ecosystem

Key Takeaways

  • Gastrostomy-Jejunostomy Tubes market is valued at $110.4 million in 2025 with projected growth to $162.5 million by 2030.
  • Gastrostomy-Jejunostomy Tubes demonstrate a 5.7% CAGR, outpacing the global enteral feeding devices market growth rate.
  • Gastrostomy-Jejunostomy Tubes benefit from dual-access design advantages that reduce feeding intolerance and aspiration risks.
  • Gastrostomy-Jejunostomy Tubes adoption is accelerated by aging demographics and increased prevalence of chronic gastrointestinal conditions.

Enteral Feeding Devices Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment CONSUMABLES AND ACCESSORIES (Product)
Forecast Period 2025–2030
Growth Rate CAGR of 5.5% from 2025 to 2030
Largest Segment TRANSNASAL, TRANSORAL, AND PERCUTANEOUS ENDOSCOPIC INSERTION (Insertion Method)
Market Size Base Year (Billions) ~USD 3.27 (2025)
Revenue Forecast (Billions) ~USD 4.28 (2030)
Segments Covered Product, Type, Age Group, Insertion Method, Application, End User

Oncology Enteral Feeding Devices Market Report Segmentation

6 segment dimensions are covered across the global market.

By Product

  • Administration Sets
  • Consumables And Accessories
  • Enteral Feeding Pumps
  • Enteral Feeding Tubes
  • Enteral Syringes

By Type

  • Administration Sets
  • Connectors/Caps/
  • Connectors/Caps/Adapters
  • Consumables & Accessories
  • Enteral Feeding Pumps
  • Enteral Feeding Tubes
  • Enteral Syringes
  • Esophageal Cancer
  • Flush/Irrigation Accessories
  • Gastric/ Gastrostomy Tubes
  • Gastric/Gastrostomy Tubes
  • Gastrostomy-Jejunostomy Tubes
  • Head & Neck Cancers
  • Jejunostomy Tubes
  • Liver Cancer
  • Low-Profile Gastrostomy Tubes
  • Low-Profile Gastrostomy-Jejunostomy Tubes
  • Low-Profile Jejunostomy Tubes
  • Nasal Feeding Tubes
  • Nasoduodenal Tubes
  • Nasogastric Tubes
  • Nasojejunal Tubes
  • Oral Feeding Tubes
  • Oroenteric Tubes
  • Orogastric Tubes
  • Other Accessories
  • Other Cancers
  • Pancreatic Cancer
  • Portable Enteral Feeding Pumps
  • Private Hospitals
  • Public Hospitals
  • Standard Gastrostomy Tubes
  • Standard Gastrostomy-Jejunostomy Tubes
  • Standard Jejunostomy Tubes
  • Stationary Enteral Feeding Pumps
  • Stomach & Gi Cancers
  • Stopcocks
  • Tube Stabilizers/Fixation Devices

By Age Group

  • Adult Patients
  • Geriatric Pateints
  • Neonatal Patients
  • Pediatric Patients

By Insertion Method

  • Radiological Insertion
  • Radiological Insertion (Rig/Rij)
  • Surgical Insertion
  • Transnasal, Transoral, And Percutaneous Endoscopic Insertion

By Application

  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Hypermetabolism
  • Neurological Disorders
  • Oncology
  • Other Applications
  • Respiratory Disorders

By End User

  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals
  • Other End Users

Target Audience

  • Medical Device Manufacturers : Identify market opportunities, competitive landscape, and emerging trends to guide product development, innovation strategies, and market expansion initiatives.
  • Healthcare Providers : Understand market offerings, technology advancements, and best practices to optimize patient care delivery and procurement decisions for enteral feeding solutions.
  • Investment & Private Equity Firms : Evaluate market growth potential, segment performance, and regional opportunities to make informed investment decisions in the healthcare nutrition sector.
  • Healthcare Consultants : Access comprehensive market data and insights to support client advisory services, strategic planning, and competitive analysis in the enteral nutrition market.
  • Regulatory & Policy Bodies : Leverage market intelligence to inform healthcare policy development, reimbursement strategies, and regulatory frameworks for enteral feeding devices.

Key Companies in the Oncology Enteral Feeding Devices Market

CompanyHQOwnershipStrongest segments
WILO SEGermanyPrivate CompanyBuilding Services Residential,Building Services Commercial,Original Equipment Manufacturers,
FRESENIUS SE & CO. KGAAGermanyPublic CompanyHelios hospitals and care delivery,Injectable generics and IV fluids,Clinical nutrition (enteral and parenteral),
CARDINAL HEALTHUnited StatesPublic CompanyBranded and generic pharmaceutical distribution,Specialty pharmaceutical and manufacturer services,Medical, surgical, and laboratory products (Cardinal brand and national brands),
NESTLÉ S.A.SwitzerlandPublic CompanyAmbient and chilled food (culinary, frozen, chilled, dairy, ice cream),Beverages and coffee (Nescafé, Nespresso, Starbucks At Home, water, drinks),Confectionery and cereals,
AVANOS MEDICAL, INC.United StatesPublic CompanyDigestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain solutions (COOLIEF, Trident, Esentec RFA),
DANONE S.A.FrancePublic CompanyEssential Dairy & Plant-Based,Specialized Nutrition (Infant & Medical),Waters & Beverages,
BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, rhythm management, peripheral),MedSurg Endoscopy (GI, pancreaticobiliary, infection prevention),Urology and Pelvic Health,
BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (needles, syringes, catheters, sharps, basic disposables),Connected Care (infusion, IV medication safety, dispensing, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems and related solutions),
B. BRAUN MELSUNGEN AGGermanyPrivate CompanyInfusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Pharma and drug delivery systems (components, systems, clinical trial supplies),
CONMED CORPORATIONUnited StatesPublic CompanySports medicine and orthopedic surgery (implants, resection, visualization),Powered instruments (Hall large and small bone systems),General surgery (AirSeal, Buffalo Filter, endomechanical),
BAXTER INTERNATIONAL INC.United StatesPublic CompanySterile IV solutions and infusion systems,Generic and specialty injectable pharmaceuticals,Parenteral nutrition and respiratory therapies,
ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
MOOG, INC.United StatesPublic CompanySpace and Defense,Military Aircraft,Commercial Aircraft,
TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,

WILO SE

Wilo SE is a German private company established in 1872 with 8,442 employees, specializing in pump and motor technology.

FRESENIUS SE & CO. KGAA

Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees, operating in healthcare and pharmaceutical sectors.

CARDINAL HEALTH

Cardinal Health is a United States public company founded in 1979 with 55,392 employees, serving the healthcare industry.

NESTLÉ S.A.

Nestlé S.A. is a Swiss public company established in 1866 with 271,000 employees, operating as a global food and beverage manufacturer.

AVANOS MEDICAL, INC.

Avanos Medical, Inc. is a United States public company founded in 2014 with 2,287 employees in the medical device sector.

DANONE S.A.

Danone S.A. is a French public company established in 1899 with 88,670 employees, specializing in food and beverage products.

BOSTON SCIENTIFIC CORPORATION

Boston Scientific Corporation is a United States public company founded in 1979 with 59,000 employees, developing medical devices and technologies.

BECTON, DICKINSON AND COMPANY

Becton, Dickinson and Company is a United States public company established in 1897 with 72,000 employees, manufacturing medical devices and diagnostic products.

B. BRAUN MELSUNGEN AG

B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical industries.

CONMED CORPORATION

Conmed Corporation is a United States public company founded in 1970 with 3,900 employees, specializing in surgical and patient monitoring equipment.

BAXTER INTERNATIONAL INC.

Baxter International Inc. is a United States public company established in 1931 with 37,500 employees, producing medical devices and pharmaceuticals.

ABBOTT

Abbott is a United States public company founded in 1888 with 115,000 employees, operating in diagnostics, medical devices, and pharmaceuticals.

MOOG, INC.

Moog, Inc. is a United States public company established in 1951 with 13,500 employees, manufacturing motion control and aerospace components.

TERUMO CORPORATION

Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, manufacturing medical devices and blood products.

Oncology vs. other regions

HowOncology compares to the other 3 regional blocs covered in this market.

Global
~USD 35.6 Million · 5.8% wtd CAGR ·
North America
~USD 7.4 Million · 3.9% wtd CAGR ·
Europe
~USD 33.6 Million · 4% wtd CAGR ·
Asia Pacific
~USD 12.8 Million · 4.1% wtd CAGR ·

Countries within Oncology - compare and drill down

Country2025 size (native)

Country market size visualization

Reasons to Buy this Report

  • Strategic Market Insights : Gain comprehensive understanding of market dynamics, growth drivers, and restraints to inform strategic business decisions and competitive positioning in the enteral feeding devices sector.
  • Segment-Level Analysis : Access detailed breakdowns across six market segments including products, types, age groups, insertion methods, applications, and end users for targeted market opportunities.
  • Regional Market Intelligence : Understand regional variations and growth potential across North America, Europe, and Asia Pacific to identify high-growth markets and expansion opportunities.
  • Disease-Specific Insights : Explore market dynamics specific to Oncology and Gastrointestinal Disorders, enabling focused product development and marketing strategies for key patient populations.
  • Long-Term Forecasting : Leverage 14-year market projections through 2039 to develop sustainable growth strategies, investment plans, and product roadmaps aligned with future market demands.

Frequently asked questions

What is the market size of Gastrostomy-Jejunostomy Tubes in 2025?

Gastrostomy-Jejunostomy Tubes market is estimated at $110.4 million in 2025.

What is the projected market size for Gastrostomy-Jejunostomy Tubes by 2030?

Gastrostomy-Jejunostomy Tubes market is forecasted to reach $162.5 million by 2030.

What is the CAGR for Gastrostomy-Jejunostomy Tubes?

Gastrostomy-Jejunostomy Tubes are expected to grow at a 5.7% compound annual growth rate from 2025 to 2030.

Why are Gastrostomy-Jejunostomy Tubes preferred over single-access feeding tubes?

Gastrostomy-Jejunostomy Tubes offer dual-access capability, reducing feeding intolerance, aspiration risk, and improving nutritional delivery in complex patient populations.

What factors are driving growth in the Gastrostomy-Jejunostomy Tubes segment?

Gastrostomy-Jejunostomy Tubes growth is driven by aging populations, increased chronic disease prevalence, improved clinical protocols, and expanding reimbursement coverage.

RESEARCH METHODOLOGY

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the comprehensive use of secondary sources, directories, databases (such as Factiva, Bloomberg Businessweek, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the enteral feeding devices market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. Moreover, a database of the key industry leaders was prepared using secondary research.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and related key executives from various companies and organizations in enteral feeding devices market. The primary sources from the demand side include medical OEMs, analytical instrument OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on industry trends & market dynamics.

A breakdown of the primary respondents is provided below:

Enteral Feeding Devices Market

Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

In this report, the size of the enteral feeding devices market was determined using revenue analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the enteral feeding device business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. Meanwhile, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and marketing executives.

Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

  • Generating a list of major global players operating in the enteral feeding devices market
  • Mapping annual revenues generated by major global players from the enteral feeding devices market (or nearest reported business unit/product category)
  • Revenue mapping of key  players to cover a major share of the global market as of 2024
  • Extrapolating the global value of the enteral feeding devices market
Enteral Feeding Devices Market

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the enteral feeding devices market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the enteral feeding devices market was validated using top-down and bottom-up approaches.

Market Definition

Enteral feeding devices are instruments and configurations designed for nutrition administration directly into the gastrointestinal tract, bypassing the mouth. These devices serve medically challenged patients who cannot eat food orally due to swallowing disorders, severe illnesses, or surgical interferences. Enteral feeding can be accomplished through the insertion of tubes from the nose or mouth, which are then placed into the stomach or small intestine to deliver nutrients.

Stakeholders

  • Manufacturers and Distributors of Enteral Feeding Devices
  • Ambulatory Surgical Centers
  • Home Care Facilities
  • Healthcare Institutions (Hospitals and Cardiac Centers)
  • Research Institutions
  • Research and Consulting Firms
  • Contract Research Organizations (CROS) and Contract Manufacturing Organizations (CMOS)
  • Academic Medical Centers and Universities
  • Market Research and Consulting Firms
  • Clinical Research Organizations
  • Group Purchasing Organizations (GPOs)
  • Academic Medical Centers and Universities
  • Accountable Care Organizations (ACOs)

Report Objectives

  • To define, describe, and forecast the enteral feeding devices market on product, age group, application, and end user
  • To identify and analyze drivers, restraints, opportunities, and challenges influencing market growth
  • To strategically analyze micro markets concerning individual growth trends, prospects,  and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key market players and comprehensively analyze their market shares and core competencies
  • To forecast the revenue of market segments concerning five regions, namely North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC and Rest of Middle East & Africa)
  • To analyze competitive developments such as acquisitions, agreements, collaborations, expansions, partnerships, and product launches/approvals in the enteral feeding devices market

 

Get the Full Enteral Feeding Devices Market Report

Full forecast, segment splits, and company analysis for all Enteral Feeding Devices Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status